A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)

✍ Scribed by Ralf G. Meyer; Cedrik M. Britten; Ulrike Siepmann; Barbara Petzold; Tolga A. Sagban; Hans A. Lehr; Bernd Weigle; Marc Schmitz; Luis Mateo; Burkhard Schmidt; Helga Bernhard; Thilo Jakob; Rüdiger Hein; Gerold Schuler; Beatrice Schuler-Thurner; Stephan N. Wagner; Ingo Drexler; Gerd Sutter; Nathaly Arndtz; Paul Chaplin; Jost Metz; Alexander Enk; Christoph Huber; Thomas Wölfel

• Publisher: Springer-Verlag
• Year: 2004
• Tongue: English
• Weight: 495 KB
• Volume: 54
• Category: Article
• ISSN: 0340-7004
• DOI: 10.1007/s00262-004-0616-7